Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$0.18 - $0.86 $21,487 - $102,661
-119,374 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$0.6 - $1.06 $7,955 - $14,054
-13,259 Reduced 10.0%
119,374 $72,000
Q4 2021

Feb 11, 2022

BUY
$0.85 - $1.4 $5,588 - $9,205
6,575 Added 5.22%
132,633 $119,000
Q3 2021

Nov 04, 2021

SELL
$1.33 - $1.77 $2,058 - $2,739
-1,548 Reduced 1.21%
126,058 $168,000
Q2 2021

Aug 11, 2021

BUY
$1.41 - $1.94 $9,507 - $13,081
6,743 Added 5.58%
127,606 $184,000
Q1 2021

May 13, 2021

SELL
$1.61 - $2.77 $17,003 - $29,253
-10,561 Reduced 8.04%
120,863 $217,000
Q4 2020

Feb 16, 2021

BUY
$1.55 - $2.24 $23,933 - $34,587
15,441 Added 13.31%
131,424 $230,000
Q3 2020

Nov 12, 2020

BUY
$1.91 - $3.08 $16,061 - $25,899
8,409 Added 7.82%
115,983 $226,000
Q2 2020

Aug 13, 2020

BUY
$1.97 - $3.98 $122,029 - $246,537
61,944 Added 135.75%
107,574 $297,000
Q1 2020

May 14, 2020

SELL
$1.17 - $3.0 $54,175 - $138,912
-46,304 Reduced 50.37%
45,630 $136,000
Q4 2019

Feb 14, 2020

BUY
$1.16 - $1.42 $62,522 - $76,536
53,899 Added 141.71%
91,934 $112,000
Q3 2019

Nov 14, 2019

SELL
$1.21 - $1.65 $74,909 - $102,149
-61,909 Reduced 61.94%
38,035 $49,000
Q2 2019

Aug 14, 2019

SELL
$1.39 - $2.03 $225,432 - $329,229
-162,182 Reduced 61.87%
99,944 $166,000
Q1 2019

May 15, 2019

BUY
$1.39 - $1.71 $158,354 - $194,810
113,924 Added 76.87%
262,126 $391,000
Q4 2018

Feb 14, 2019

SELL
$1.41 - $2.16 $196,506 - $301,030
-139,366 Reduced 48.46%
148,202 $212,000
Q3 2018

Dec 21, 2021

BUY
$1.86 - $2.18 $55,586 - $65,149
29,885 Added 11.6%
287,568 $603,000
Q3 2018

Nov 14, 2018

BUY
$1.86 - $2.18 $36,243 - $42,479
19,486 Added 8.18%
257,683 $540,000
Q2 2018

Apr 21, 2020

BUY
$1.76 - $2.79 $64,558 - $102,339
36,681 Added 18.2%
238,197 $469,000
Q2 2018

Aug 14, 2018

BUY
$1.76 - $2.79 $28,592 - $45,326
16,246 Added 8.77%
201,516 $396,000
Q1 2018

Oct 18, 2019

BUY
$1.34 - $2.03 $32,028 - $48,521
23,902 Added 14.81%
185,270 $338,000
Q1 2018

May 15, 2018

SELL
$1.34 - $2.03 $414,287 - $627,615
-309,170 Reduced 65.71%
161,368 $295,000
Q4 2017

Feb 14, 2018

SELL
$1.65 - $2.45 $249,508 - $370,481
-151,217 Reduced 24.32%
470,538 $851,000
Q3 2017

Nov 14, 2017

BUY
$1.5 - $2.55 $932,632 - $1.59 Million
621,755
621,755 $1.28 Million

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.